Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors

OBJECTIVE: To identify predictors of flare in a 2-year follow-up study of patients with rheumatoid arthritis (RA) in sustained clinical remission tapering towards withdrawal of biological disease-modifying anti-rheumatic drugs (bDMARDs). METHODS: Sustained clinical remission was defined as Disease A...

Descripción completa

Detalles Bibliográficos
Autores principales: Terslev, L, Ostergaard, Mikkel, Georgiadis, Stylianos, Brahe, Cecilie Heegaard, Ellegaard, Karen, Dohn, UM, Fana, Viktoria, Møller, Torsten, Juul, Lars, Huynh, Tuan Khai, Krabbe, Simon, Ornbjerg, L M, Glinatsi, Daniel, Røgind, Henrik, Hansen, Annette, Nørregaard, Jesper, Jacobsen, Søren, Jensen, Dorte V, Manilo, Natalia, Asmussen, Karsten, Boesen, Mikael, Rastiemadabadi, Zoreh, Morsel-Carlsen, Lone, Møller, Jakob Møllenbach, Krogh, Niels Steen, Hetland, Merete Lund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791469/
https://www.ncbi.nlm.nih.gov/pubmed/36549857
http://dx.doi.org/10.1136/rmdopen-2022-002796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791469/
https://www.ncbi.nlm.nih.gov/pubmed/36549857
http://dx.doi.org/10.1136/rmdopen-2022-002796

Ejemplares similares